PTC Therapeutics Inc. buy Quitte
Start price
03.03.16
/
50%
€5.86
Target price
05.09.16
€8.03
Performance (%)
21.69%
End price
05.09.16
€7.13
Summary
This prediction ended on 05.09.16 with a price of €7.13. The BUY prediction by Quitte finished with a performance of 21.69%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| PTC Therapeutics Inc. | 1.869% | 1.869% | 13.071% | 29.147% |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% | 53.313% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% | 93.480% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% | 52.317% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% | 66.737% |
Comments by Quitte for this prediction
In the thread PTC Therapeutics Inc. diskutieren
chancenreich
die ist nicht so schlecht wie der Absturz vermuten lässt
PTC Therapeutics (NASDAQ: PTCT) recently received a number of ratings updates from brokerages and research firms:
- 3/1/2016 – PTC Therapeutics had its price target raised by analysts at Barclays from $40.00 to $100.00. They now have an “overweight” rating on the stock.
- 3/1/2016 – PTC Therapeutics had its “outperform” rating reaffirmed by analysts at Credit Suisse. They now have a $12.00 price target on the stock, down previously from $36.00. etc etc
(Laufzeit überschritten)